Revenue and Growth - The company generated revenues of $21.4 million in the 2026 Quarter, a 364% increase from $4.6 million in the 2025 Quarter, primarily driven by its new digital asset treasury strategy [126]. - The increase in net revenues was partially offset by a $570,000 decline in design segment revenue due to the loss of a major customer [129]. Gross Margin and Profitability - Gross margin improved significantly from 24.5% in the 2025 Quarter to 78.6% in the 2026 Quarter, attributed to high-margin staking revenue from the digital asset treasury strategy [126]. - The company reported a basic and diluted loss per share from continuing operations of $5.91 for the 2026 Quarter, compared to $0.82 for the 2025 Quarter [136]. Digital Asset Strategy - The company launched fwdSOL, a Liquid Staking Token, which allows for generating staking yield on SOL while unlocking additional returns through DeFi and institutional borrowing strategies [126]. - The loss on digital assets in the 2026 Quarter was $560.2 million, driven by a decline in the market value of SOL [135]. - An impairment charge of $33.0 million was recorded for fwdSOL due to the decrease in market value of SOL, reflecting the volatility of digital asset holdings [135]. - The company tokenized 1,489,896 shares of common stock on the Solana blockchain, allowing for self-custody and use in the DeFi ecosystem [126]. - The company reported non-cash net digital asset revenue of $16,462,000 during the 2026 Quarter [140]. Expenses - Sales and marketing expenses increased to $535,000, primarily due to corporate marketing spend related to market research activities [131]. - General and administrative expenses rose to $6.7 million, largely due to higher professional fees and personnel costs associated with the digital assets treasury strategy [133]. Cash Flow and Liquidity - As of December 31, 2025, the company's working capital was approximately $52.9 million [137]. - The cash balance as of January 31, 2026, was approximately $12 million [137]. - In the 2026 Quarter, cash used in operating activities amounted to $7,929,000, resulting from a net loss of $585,651,000 [140]. - Cash used in investing activities in the 2026 Quarter included purchases of digital assets totaling $335,050,000 [142]. - Cash used in financing activities in the 2026 Quarter included share repurchases of $10,883,000 [143]. - The company executed open market purchases totaling 3,330,000 shares at an average cost of $7.32 per share, for an aggregate cost of $24,387,000 [138]. - In the 2025 Quarter, cash used in operating activities was $434,000, resulting from a net loss of $708,000 [141]. - The company anticipates that its current liquidity will remain adequate for at least the next twelve months, assuming it can liquidate digital assets as needed [137]. - The liquidity assessment does not account for potential margin calls or collateral requirements from DeFi activities [137].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Lake Superior Acquisition Corp. (Exact name of registrant as specified in its charter) | | | (State or other jurisdiction of incorporation or organization) 521 Fifth Avenu ...

Financial Performance - Aethlon Medical reported a cash balance of approximately $7.0 million as of December 31, 2025[9]. - Consolidated operating expenses for the three months ended December 31, 2025, were approximately $2.06 million, an increase of $250,000 or 13.6% from $1.81 million in the same period in 2024[10]. - Operating expenses for the nine months ended December 31, 2025, decreased by approximately $1.98 million or 26.9%, totaling approximately $5.36 million compared to $7.34 million for the same period in 2024[12]. - Other income, primarily interest income, totaled $44,000 for the three months ended December 31, 2025, compared to $60,000 in the prior-year period[11]. - Net loss for the three months ended 12/31/25 was $2,018,245, compared to a net loss of $1,754,783 for the same period in 2024, indicating an increase of 15.1%[26]. - Net loss for the nine months ended 12/31/25 was $5,267,203, a decrease of 26.1% compared to $7,133,196 for the same period in 2024[26]. - Comprehensive loss for the three months ended 12/31/25 was $2,021,705, compared to $1,767,840 for the same period in 2024, representing a 14.4% increase[26]. Cost Management - The company maintained disciplined cost controls, resulting in lower year-to-date operating expenses compared to the prior year[5]. - Total operating expenses for the three months ended 12/31/25 were $2,062,116, an increase from $1,814,747 for the same period in 2024, representing a 13.6% rise[26]. - Total operating expenses for the nine months ended 12/31/25 were $5,364,335, down 26.9% from $7,337,402 for the same period in 2024[26]. - Payroll and related expenses for the three months ended 12/31/25 were $987,424, an increase of 59.1% from $620,487 in the same period last year[26]. - General and administrative expenses for the three months ended 12/31/25 were $741,650, a decrease of 9.2% from $816,383 for the same period in 2024[26]. Clinical Development - Enrollment and treatment of participants in Cohort 2 of the Australian oncology trial is actively underway, building on favorable results from Cohort 1[4]. - The Hemopurifier is being evaluated for compatibility with a simplified blood treatment system, potentially broadening its clinical application[5]. - Aethlon's preclinical Long COVID research demonstrated that the GNA affinity resin binds EVs from patient samples, supporting the Hemopurifier's potential as a multi-indication therapeutic approach[6]. - The company continues to advance its clinical programs and research initiatives with operational discipline, aiming to deliver therapeutic solutions for cancer and life-threatening infectious diseases[9]. Shareholder Information - Basic and diluted loss per share attributable to common stockholders for the three months ended 12/31/25 was $2.45, a significant improvement from $10.05 in the same period last year[26]. - Weighted average number of common shares outstanding for the three months ended 12/31/25 was 823,126, significantly higher than 174,529 for the same period in 2024[26]. Asset Management - The total assets of Aethlon Medical as of December 31, 2025, were approximately $8.06 million, an increase from $7.36 million as of March 31, 2025[24].

Financial Results - Anebulo Pharmaceuticals reported financial results for Q4 2025, with a focus on business updates[5] Company Classification - The company is classified as an emerging growth company under the Securities Act[4] Stock Information - Anebulo Pharmaceuticals' common stock is traded on The Nasdaq Stock Market under the symbol ANEB[3]

Exhibit 99.1 Compared to the prior year fourth quarter where applicable Fiscal 2025 Summary: Compared to the prior year where applicable Chairman and CEO Remarks: "Flowers concluded 2025 on a positive note driven by the strong performance of our leading brands," said Ryals McMullian, chairman and CEO of Flowers Foods. "Our disciplined execution of efficiency initiatives produced results at the high end of our guidance range. We remain committed to implementing further enhancements to drive improved results ...

Financial Performance - Net income per share for Q4 2025 was $2.60, a decrease of 19.0% from $3.21 in Q4 2024; full-year net income per share was $9.01, down 15.3% from $10.64 in 2024[2] - Core FFO per share for Q4 2025 was $4.26, an increase of 1.2% from $4.21 in Q4 2024; full-year Core FFO per share was $16.97, up 1.8% from $16.67 in 2024[2] - Net income for the year ended December 31, 2025, was $1,797,032, down from $2,084,410 in 2024, a decrease of 13.8%[38] - Net income allocable to common shareholders decreased by 19.0% to $456,979 in Q4 2025 from $564,398 in Q4 2024[40] - Funds from Operations (FFO) allocable to common shares decreased by 10.8% to $761,581 in Q4 2025 compared to $853,679 in Q4 2024[40] - Core FFO allocable to common shares increased by 1.2% to $749,853 in Q4 2025 from $740,962 in Q4 2024[40] Revenue and Occupancy - Same Store revenue growth was positive in 56% of markets, up from 49% in Q4 2024; Same Store net operating income margin was 78.4%[4] - Self-storage revenues from same store facilities were $936,172 in Q4 2025, slightly down from $937,686 in Q4 2024[43] - Total revenues for Q4 2025 reached $1,215,792, a 3.5% increase from $1,177,427 in Q4 2024[38] - Square foot occupancy at December 31, 2025, was 91.0%, an increase of 0.5% from 90.5% in the previous year[35] - Realized annual rental income per occupied square foot for 2025 was $22.54, a 0.5% increase from $22.43 in 2024[35] - The annual contract rent per occupied square foot decreased by 0.7% to $22.55 as of December 31, 2025, compared to $22.72 in 2024[35] Expenses and Liabilities - Total expenses for Q4 2025 were $739,743, up from $702,699 in Q4 2024, reflecting a 5.3% increase[38] - Interest expense rose to $81,185 in Q4 2025, compared to $72,135 in Q4 2024, marking a 12.8% increase[38] - As of December 31, 2025, the company had total indebtedness of $10.3 billion, with a weighted average interest rate of 3.2% and a weighted average term of 6.3 years[16] - Total liabilities rose to $10,866,770, compared to $9,941,282, reflecting an increase of approximately 9.3%[45] Acquisitions and Developments - The company acquired 13 self-storage facilities for $131.0 million, adding 0.9 million net rentable square feet; total acquisitions for the year reached 90 facilities for $966.3 million[11] - New developments and expansions added 1.0 million net rentable square feet at a cost of $140.1 million in Q4 2025; for the year, 2.1 million net rentable square feet were added at a cost of $408.9 million[12] - The company is in the process of developing facilities expected to add 3.5 million net rentable square feet at an estimated cost of $609.9 million over the next 18 to 24 months[13] Strategic Vision and Management - PS4.0 was announced as a new strategic vision aimed at enhancing shareholder returns and improving customer and employee experiences[18] - The company managed 362 facilities through its third-party property management program, with an additional 84 facilities under contract[15] Market Conditions and Future Outlook - The company anticipates potential impacts from inflation and macroeconomic conditions on future performance, as outlined in their forward-looking statements[31] - The company expects Same Store revenue growth in 2026 to range from (2.2)% to 0%; Core FFO per share guidance is set between $16.35 and $17.00[6] Financial Position - Total assets increased to $20,208,604, up from $19,754,934, representing a growth of approximately 2.3% year-over-year[45] - Cash and equivalents decreased to $318,095 from $447,416, a decline of about 29%[45] - Public Storage shareholders' equity decreased to $9,248,128 from $9,712,606, a decline of about 4.8%[45] - Accumulated deficit increased to $(1,219,273) from $(699,083), indicating a worsening financial position[45] - Total real estate facilities, net, increased to $18,804,558 from $18,360,653, a growth of approximately 2.4%[45] - Notes payable increased to $10,253,881 from $9,353,034, an increase of about 9.6%[45] - Investment in unconsolidated real estate entity rose to $388,586 from $382,490, a slight increase of about 1.3%[45] - Accumulated other comprehensive loss improved to $(47,799) from $(71,965), indicating a positive change[45] - Construction in process decreased to $194,355 from $308,101, a decline of approximately 37%[45]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Commission File Number 1-8022 CSX CORPORATION (Exact name of registrant as specified in its charter) | Virginia | | | 62-1051971 | | | | --- | --- | --- | --- | --- | --- | | (State or other jurisdiction of incorporation | | | | | | | or organization) | | | (I.R.S. Employer Identification No.) | | | | 500 Water Street FL 32202 | 15th Floor | Jacksonville | | 904 | 359-3200 | | (Address of principal executive offices) (Zip Code ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-40896 INVENTRUST PROPERTIES CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organ ...

Exhibit 99.1 Bright Horizons Family Solutions Reports Financial Results for the Fourth Quarter and Full Year of 2025 NEWTON, MA - (BUSINESS WIRE) - February 12, 2026 - Bright Horizons Family Solutions Inc. (NYSE: BFAM) today announced financial results for the fourth quarter and full year of 2025 and provided guidance for 2026. Bright Horizons is a leading provider of high-quality early education and child care, comprehensive back-up care solutions, and educational advisory services. Our offerings are desig ...

FORM 10-Q ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2025 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from to . Commission File Number 0-10843 CSP Inc. (Exact name of Registrant as specified in its charter) Massachusetts 04-2441294 (State or other jurisdi ...